Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hullett, D. A.
Right arrow Articles by Sollinger, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hullett, D. A.
Right arrow Articles by Sollinger, H. W.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 38, Issue 4 448-453, Copyright © 1989 by American Diabetes Association


ARTICLES

Successful long-term cryopreservation and transplantation of human fetal pancreas

DA Hullett, KP Bethke, AS Landry, DK Leonard and HW Sollinger
Department of Surgery, University of Wisconsin - Madison 53792.

To obtain sufficient quantities of human fetal pancreatic tissue (HFP) for transplantation, long-term storage of the tissue must be achieved. The functional viability of HFP after cryopreservation by stepwise addition of dimethyl sulfoxide was determined. Human fetal pancreas explants (1-2 mm3; gestational age 16-21 wk) were prepared and slowly cooled (0.25 degrees C/min) to -40 degrees C before placement in liquid nitrogen. After rapid thaw (37 degrees C) and overnight culture, insulin release in response to high glucose and theophylline challenge determined in vitro functional viability. No difference was found between the responses of fresh and cryopreserved tissue (fresh 29.2 +/- 3.0 ng/mg tissue, cryopreserved 29.9 +/- 3.3 ng/mg tissue; P greater than .1). Diabetic BALB/c nu/nu mice transplanted with cryopreserved HFP returned to normoglycemia in 11 +/- 2 wk (range 8-15 wk). Oral glucose tolerance tests indicated in vivo serum glucose control equivalent to or better than that of nondiabetic control mice (peak serum glucose of nondiabetic mice 164 +/- 66 mg/dl, of cryopreserved grafted mice 180 +/- 67 mg/dl; P greater than .8). In vitro insulin release of cryopreserved grafted tissue demonstrated that the tissue had differentiated and matured and was now capable of responding to high-glucose challenge (39.3 +/- 11.5 ng insulin released/mg tissue). The results described herein are the first demonstration that cryopreserved HFP maintains the in vivo capacity to differentiate and mature and the capacity to reverse diabetes in an animal system.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
K. Kushibe, K. Nezu, K. Nishizaki, M. Takahama, and S. Taniguchi
Tracheal allotransplantation maintaining cartilage viability with long-term cryopreserved allografts
Ann. Thorac. Surg., May 1, 2001; 71(5): 1666 - 1669.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Hayek and G. M. Beattie
Experimental Transplantation of Human Fetal and Adult Pancreatic Islets
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2471 - 2475.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1989 by the American Diabetes Association.